Liverpool University Hospitals NHS Foundation Trust
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2019-10-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.rlbuht.nhs.uk
Clinical Trials
75
Active:8
Completed:37
Trial Phases
5 Phases
Phase 1:7
Phase 2:2
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (41 trials with phase data)• Click on a phase to view related trials
Not Applicable
25 (61.0%)Phase 1
7 (17.1%)Phase 3
4 (9.8%)Phase 4
3 (7.3%)Phase 2
2 (4.9%)Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment
Not Applicable
Not yet recruiting
- Conditions
- Retinal Detachment Rhegmatogenous
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Target Recruit Count
- 150
- Registration Number
- NCT07034469
Intelligent Monitoring to Predict Atrial Fibrillation
Suspended
- Conditions
- Atrial Fibrillation New OnsetAtrial FibrillationPostoperative Cardiovascular Complications
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-06-25
- Target Recruit Count
- 1200
- Registration Number
- NCT06600620
- Locations
- 🇬🇧
Liverpool university foundation trust, Liverpool, United Kingdom
🇬🇧Liverpool University hospital Foundation trust, Liverpool, United Kingdom
Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis
Not Applicable
Not yet recruiting
- Conditions
- Acute PancreatitisOrgan Failure, Multiple
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2025-03-20
- Target Recruit Count
- 20
- Registration Number
- NCT06566638
- Locations
- 🇬🇧
Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD
Phase 3
Recruiting
- Conditions
- Iron Deficiency AnemiaInflammatory Bowel Disease
- Interventions
- Drug: Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron)Drug: Ferrous fumarate syrup 2.5ml/70mg(45mg elemental iron)Drug: Ferrous fumarate syrup 2.5ml/70mg (90mg elemental iron)
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-03-20
- Target Recruit Count
- 30
- Registration Number
- NCT06321887
- Locations
- 🇬🇧
Liverpool University Foundation NHS Trust, Liverpool, United Kingdom
ADAPT-AST (Adaptive Antimicrobial Susceptibility Testing)
Active, not recruiting
- Conditions
- Urinary Tract Infections
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2025-02-04
- Target Recruit Count
- 500000
- Registration Number
- NCT06297837
- Locations
- 🇬🇧
Liverpool University Hospitals NHS Foundation Trust, Liverpool, North West, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
News
No news found